L-Carnitine Treatment Guidelines
Primary Carnitine Deficiency
- The American College of Medical Genetics recommends L-carnitine as the definitive treatment for primary carnitine deficiency, a genetic disorder affecting carnitine transport into cells, with dosing requiring 50-100 mg/kg/day (approximately 3 g/day in adults) 1
- Treatment should continue lifelong as this is a genetic transporter defect requiring permanent replacement, with clinical improvement occurring rapidly within days to weeks, and normalization of carnitine levels and the acyl-to-free carnitine ratio (normal ≤0.25, deficiency >0.4) 1
Secondary Carnitine Deficiency
- Standard supplementation doses of 0.5-1 g/day are recommended for patients at risk, including those on prolonged parenteral nutrition or chronic hemodialysis, with confirmed secondary deficiency requiring 2-5 mg/kg/day until normalization of carnitine levels 2
Cardiovascular Applications
- The American Heart Association may consider 2-3 g daily for patients with cardiac dysautonomia or reduced heart rate variability, with monitoring for side effects, and therapeutic doses of 1.5-3 g daily may improve exercise tolerance and oxygen consumption in moderate to severe heart failure 3
Dialysis-Related Complications
- The National Kidney Foundation guidelines state that there is insufficient evidence to support routine use of L-carnitine in dialysis patients, but a trial of L-carnitine may be considered only in selected individuals who manifest symptoms and have not responded adequately to standard therapies 4, 5
Diagnostic Evaluation
- Serum free carnitine, total carnitine, and acylcarnitine esters should be obtained to calculate the acyl-to-free carnitine ratio, along with blood triglycerides, liver function tests, glucose, lactate, and ammonia, and urine ketones 1, 2
Side Effects and Monitoring
- Common side effects include gastrointestinal symptoms, such as nausea, vomiting, abdominal cramps, and diarrhea, as well as fishy body odor, particularly at doses ≥3 g/day 1, 2, 3
- Rare but serious side effects include muscle weakness in uremic patients and seizures in patients with pre-existing seizure disorders 1, 2